椎体血管瘤治疗进展  

Treatment of Vertebral Hemangiomas

作　　者：崔燕明[1] 刘泽汉[1] 王立春[1] 

机构地区：[1]哈尔滨医科大学附属第二医院脊柱外科,哈尔滨150086

出　　处：《医学综述》2018年第3期512-516,共5页Medical Recapitulate

摘　　要：椎体血管瘤(VH)属于脊柱原发的良性肿瘤,可发生于任何年龄,女性多发。VH可能被误认为恶性肿瘤,导致不必要的活检,出血风险高。血管瘤可呈弥漫性生长,可扩展至椎管的硬膜外区域,从而引起脊髓压迫和瘫痪。VH患者绝大多数没有症状,不需临床特殊干预治疗,而对于出现脊髓压迫的临床症状可通过脊柱后路的手术减压、栓塞或放射治疗等手段来缓解。目前的公认治疗方法主要有保守治疗、微创治疗、联合手术治疗等。Vertebral hemangiomas（ VH） are primary benign tumors of the spine that can occur at any age,and more frequently in women. VH may be mistaken for malignancy,leading to unnecessary biopsy and high risk of bleeding. Hemangiomas can show diffusive growth,extending to the epidural spinal canal,causing spinal cord compression and paralysis. The vast majority of VH patients have no symptoms,needing no special clinical intervention; for the emergence of clinical symptoms of spinal cord compression,posterior spinal surgery decompression,embolization or radiation therapy can be adopted to alleviate the symptoms. The main recognized treatments are conservative treatment,minimally invasive treatment,and combined surgical treatment.

关 键 词：椎体血管瘤 微创治疗 联合治疗 

分 类 号：R605[医药卫生—外科学]